Healthtech Startups

A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.

1 investor

Invive applies epigenetics to life insurance, using a saliva test to measure lifestyle factors such as smoking and alcohol consumption as an alternative to the blood-test standard. It targets insurers, reinsurers, and distributors in the insurance industry.

1 investor

InVivo Bionics develops implantable sensor systems for medical monitoring, initially focused on bladder health in urology. The company combines expertise in sensor electronics, software, and medical devices to create minimally invasive monitoring solutions with potential applications across multiple organ systems.

1 investor

Invizius develops therapeutics targeting the complement system to treat kidney disease and other disorders driven by uncontrolled immune activation. The company was founded based on research from the University of Edinburgh and operates from Glasgow Biocity.

1 investor

Invoke develops personalized cancer treatments using computational biology to predict neoantigens with greater accuracy by modeling individual tumor evolution and immune dynamics. The company serves cancer patients through neoantigen prediction models designed for treatment personalization.

1 investor

Invoy offers a breath-based metabolic testing tool that provides real-time, non-invasive metabolic data to help individuals and communities prevent chronic disease and change health behavior. It is positioned for public health leaders as a scalable approach to earlier intervention and lower long-term healthcare costs.

1 investor

Sophisticated optics for illumination and enhanced visualization in surgical procedures.

1 investor

IO Health is an intelligence layer that integrates into existing EMR systems for home health and hospice agencies, providing real-time clinical documentation guidance at point of care, automated QA prioritization, and operational visibility. The platform reduces QA workload and improves documentation accuracy without requiring new systems, logins, or workflow disruption.

1 investor

A health data platform aligned with European Health Data Space regulations that enables secondary use of clinical data from hospitals and healthcare providers. The platform facilitates data access for research, feasibility studies, and real-world evidence generation while ensuring regulatory compliance and patient privacy.

1 investor

IOMED is a data space platform that uses AI and natural language processing to extract and structure clinical data from hospital text sources, turning it into research-ready real-world data. It serves hospitals and life science companies seeking secure, compliant access to real-world clinical data for research, operating across an EU5 hospital partner network harmonized under the OMOP Common Data Model.

1 investor

Iona Mind develops low-intensity cognitive behavioral therapy (CBT) digital health products for behavioral and mental health management. The company specializes in customizable, evidence-based platforms that enable patients to access psychological support at their own pace with 24/7 care team support.

1 investor

A contract manufacturer offering turnkey supplement and nutraceutical production services, including capsules, gummy vitamins, tablets, powders, and liquid formulations for consumer brands.

1 investor

Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.

1 investor

Ipca is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 active pharmaceutical ingredients (APIs) for various therapeutic segments, serving healthcare markets across 120 countries. The company operates fully-automated manufacturing facilities approved by major regulatory authorities including UK-MHRA, EDQM-Europe, and WHO-Geneva.

1 investor

Implant Preservation Devices develops orthopedic implant devices for medical and surgical applications. The company focuses on launching and commercializing orthopedic implant solutions across European and emerging markets.

1 investor

IPD Products develops air sterilization systems using active technology for residential and commercial environments. The company focuses on providing hygienic air quality solutions for homes and offices.

1 investor

iPeace develops automated manufacturing systems for iPS cell production using biotech and engineering techniques to reduce production costs and enable mass manufacturing of clinical-grade stem cells. The company serves the regenerative medicine and pharmaceutical research sectors with mass-produced, personalized cell lines.

1 investor

IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Its technology originated from research at Weill Cornell Medicine and the Hospital for Special Surgery, and it is advancing these preclinical programs toward clinical applications.

1 investor

Independence Products manufactures protective pouches and personal care supplies for patients with chronic catheters, enabling them to shower and perform daily activities safely. The company operates in the UK with in-house manufacturing, customer service, and home delivery.

1 investor

iQ Sense develops biosensing tools that combine nanotechnology and artificial intelligence to detect signs of animal disease earlier, serving the veterinary and animal-health industry. The company runs programs in the UK, Australia, and USA and partners with universities, research bodies, and animal-health companies.

1 investor

IQ Surgical is developing a platform intended to improve surgical outcomes using data and intelligence. The site is a pre-launch "Coming Soon" page with limited detail about the product.

1 investor

IQIRVO is a prescription medicine for treating primary biliary cholangitis (PBC) in adults, used either in combination with ursodeoxycholic acid or as a standalone treatment for patients unable to tolerate standard therapy.

1 investor

iRen develops medical technology for dialysis patients, enabling them to continue daily activities while undergoing treatment. The company aims to reduce the burden of dialysis on quality of life for people with kidney disease.

1 investor

Iris Telehealth provides telepsychiatry and behavioral health services to health systems, hospitals, and community clinics through a medical group of psychiatrists, LCSWs, and PMHNPs. The Joint Commission-accredited company supports partner organizations in delivering psychiatric care across all ages, acuity levels, and diagnoses in the United States.

1 investor